Market open
Dr Martens /£DOCS
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Dr Martens
Dr. Martens, also known as Docs or DMs, is a United Kingdom-based company renowned for its iconic range of footwear, alongside a variety of clothing and accessories. The company, headquartered in Wollaston, Northamptonshire, operates primarily in the footwear manufacturing sector. Established in 1947, Dr. Martens has grown to become a symbol of self-expression and counterculture, distributing its products worldwide under the Dr. Martens brand.
Ticker
£DOCS
Sector
Trading on
LSE
Industry
Textiles, Apparel & Luxury Goods
Headquarters
Employees
2,630
ISIN
GB00BL6NGV24
Website
Dr Martens Metrics
BasicAdvanced
£577M
19.55
£0.03
0.06
£0.02
3.09%
Price and volume
Market cap
£577M
Beta
0.06
52-week high
£0.93
52-week low
£0.43
Average daily volume
1.5M
Dividend rate
£0.02
Financial strength
Current ratio
2.261
Quick ratio
0.976
Long term debt to equity
118.954
Total debt to equity
134.439
Dividend payout ratio (TTM)
51.02%
Interest coverage (TTM)
2.28%
Management effectiveness
Return on assets (TTM)
4.53%
Return on equity (TTM)
8.42%
Valuation
Price to earnings (TTM)
19.55
Price to revenue (TTM)
0.707
Price to book
1.72
Price to tangible book (TTM)
9.47
Price to free cash flow (TTM)
2.797
Dividend yield (TTM)
3.09%
Growth
Revenue change (TTM)
-17.55%
Earnings per share change (TTM)
-70.40%
3-year revenue growth (CAGR)
-0.77%
3-year earnings per share growth (CAGR)
-16.92%
3-year dividend per share growth (CAGR)
14.68%
What the Analysts think about Dr Martens
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Dr Martens stock.
Dr Martens Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Dr Martens Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs
What’s the current market cap for Dr Martens stock?
Dr Martens (DOCS) has a market cap of £577M as of May 14, 2025.
What is the P/E ratio for Dr Martens stock?
The price to earnings (P/E) ratio for Dr Martens (DOCS) stock is 19.55 as of May 14, 2025.
Does Dr Martens stock pay dividends?
Yes, the Dr Martens (DOCS) stock pays dividends to shareholders. As of May 14, 2025, the dividend rate is £0.0184 and the yield is 3.09%. Dr Martens has a payout ratio of 51.02% on a trailing twelve-month basis.
When is the next Dr Martens dividend payment date?
The next Dr Martens (DOCS) dividend payment date is unconfirmed.
What is the beta indicator for Dr Martens ?
Dr Martens (DOCS) has a beta rating of 0.06. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.